HSIC

Henry Schein, Inc.

$88.74

0.37%
SectorHealthcareIndustryMedical DistributionCountryUnited States

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand.

Source: Yahoo Finance
AI summary

Price & performance

1M+4.0%
3M-1.0%
YTD+14.9%
1Y+23.2%
52-week range—
Beta0.59
Full chart and returns against a benchmark

Q-Score

67/ 100

Quality against peers; 50 is the peer median.

Growth55
Risk80
Performance54
Valuation69
Profitability65
Leverage54
Sentiment38
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$13.2B+4.0%
Net income$398M+2.1%
Net margin3.0%-0.1 pts
Historical fundamentals

Revenue exposure

31%of revenue from outside the US
United States69%
Non Us31%
Regions, segments, customers and suppliers

Valuation

HSICIndustryP/E23.3028.60P/S0.710.25EV/EBITDA11.6617.46P/B3.113.11PEG3.040.72
Dividend yield0.00%
Every valuation metric

Earnings

Nov 3next report, before the open
EPS estimate$1.36
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate